瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

R 瑞德系统

交易中 09-21 11:29:42 EDT

234.95

-3.59

-1.50%

最高238.27	最低234.14	成交量3.12万
今开238.27	昨收238.54	日振幅1.73%
总市值90.10亿	流通市值86.59亿	总股本3,835万
成交额732.82万	换手率0.08%	流通股本3,685万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"R","market":"US","secType":"STK","nameCN":"瑞德系统","latestPrice":234.95,"timestamp":1790004579001,"preClose":238.54,"halted":0,"volume":31172,"delay":0,"changeRate":-0.015049886811436252,"floatShares":36853364,"shares":38346868,"eps":12.325055,"marketStatus":"交易中","change":-3.59,"latestTime":"09-21 11:29:42 EDT","open":238.27,"high":238.27,"low":234.14,"amount":7328175.91652,"amplitude":0.017314,"askPrice":235.24,"askSize":9,"bidPrice":234.83,"bidSize":1,"shortable":3,"etf":0,"ttmEps":12.325055,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790020800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":238.54,"dividendRate":0.015493,"preHourTrading":{"tag":"盘前","latestPrice":239.24,"preClose":238.54,"latestTime":"08:40 EDT","volume":27,"amount":6455.29014,"timestamp":1789994435929,"change":0.7,"changeRate":0.002935,"amplitude":0.002809},"postHourTrading":{"tag":"盘后","latestPrice":238.5425,"preClose":238.54,"latestTime":"19:48 EDT","volume":89442,"amount":21335524.7892,"timestamp":1789775318125,"change":0.0025,"changeRate":0.00001,"amplitude":0.000021},"volumeRatio":0.324016,"impliedVol":0.3239,"impliedVolPercentile":0.2629},"requestUrl":"/m/hq/s/R","defaultTab":"news","newsList":[{"id":"1193749236","title":"新闻稿：SCYNEXIS任命Todd Minga博士为研发高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1193749236","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193749236?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:03","pubTimestamp":1789473821,"startTime":"0","endTime":"0","summary":"新泽西州泽西城，2026年9月15日——SCYNEXIS，Inc.是一家专注于推进严重罕见疾病创新解决方案的临床阶段生物技术公司。该公司今日宣布，任命Todd Minga医学博士为研发高级副总裁，自2026年9月14日起生效。Minga博士拥有二十多年涵盖临床医学、药物研发、医学事务、临床研究以及肾脏疾病和罕见疾病领域战略领导的丰富经验。\"能在公司发展的这一重要阶段加入SCYNEXIS，我感到非常兴奋，\"Minga博士表示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4007","SCYX","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166023292","title":"NewtekOne宣布派发普通股及B系列优先股股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1166023292","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166023292?lang=zh_cn&edition=full","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"佛罗里达州博卡拉顿，2026年9月14日——NewtekOne, Inc.今日宣布，其董事会已批准对公司已发行普通股派发每股0.19美元的季度现金股息。该股息将于2026年10月1日支付，股权登记日设定为2026年9月24日。NewtekOne或其代表所作的任何前瞻性声明仅代表截至声明发布之日的情况，NewtekOne不承担更新前瞻性声明以反映声明发布后发生的情况或事件影响的义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEWTP","BK4022","BK4135","BK4184","BK4232","R","NEWT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199775356","title":"新闻稿：BJs餐饮公司任命Christopher W. Brandt与James D. White为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1199775356","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199775356?lang=zh_cn&edition=full","pubTime":"2026-09-10 04:30","pubTimestamp":1788985850,"startTime":"0","endTime":"0","summary":"加利福尼亚州亨廷顿海滩，2026年9月9日——BJs餐饮公司今日宣布，任命Christopher W. Brandt和James D. White为公司董事会独立董事，该任命自2026年9月3日起生效。Brandt先生将担任公司治理与提名委员会成员，而White先生则将加入董事会薪酬委员会。两位新任董事的加入，使得公司董事会成员总数增至十人。Brandt先生是一位经验丰富的商业领袖，曾任Chipotle Mexican Grill高级管理人员，于2018年至2026年期间担任总裁、首席品牌官及首席营销官。Brandt先生目前任职于好时公司和Wawa, Inc.的董事会。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BJRI","R","BK4232","BK4209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116268317","title":"新闻稿：CarGurus任命Matthew Mandel为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1116268317","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116268317?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:51","pubTimestamp":1788439906,"startTime":"0","endTime":"0","summary":"波士顿，2026年9月3日——美国访问量最大的汽车购物网站CarGurus今日宣布，任命Matthew Mandel为首席财务官，自2026年10月19日起正式生效。Mandel将直接向CarGurus首席执行官Jason Trevisan汇报，全面负责财务战略与运营管理、企业发展规划以及领导力运营。自2025年3月起，Trevisan一直兼任公司首席财务官和首席会计官。CarGurus和Autolist均为CarGurus, Inc.的注册商标，PistonHeads为CarGurus Ireland Limited在英国及欧盟的注册商标。2026 CarGurus, Inc.，保留所有权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","CARG","COO","LU1992135399.USD","BK4585","LU1992135472.HKD","BK4022","BK4077","CFO","LU2211815571.USD","BK4198","R","LU2272731600.USD","LU2272731782.SGD","GB00BDT5M118.USD","BK4588","CEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129658289","title":"新闻稿：真泰克宣布2026年第三季度现金股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1129658289","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129658289?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:00","pubTimestamp":1788177643,"startTime":"0","endTime":"0","summary":"密歇根州齐兰，2026年8月31日——总部位于密歇根州齐兰的真泰克公司今日宣布，其董事会近期已宣派每股0.12美元的季度现金股息。该股息将于2026年10月21日支付，登记在册的普通股股东需在2026年10月7日营业结束时完成登记。关于公司概况：真泰克公司成立于1974年，是数字视觉、车联网、可调光玻璃、消防技术、医疗器械以及消费电子领域的领先供应商。联系方式：真泰克投资者关系部门，电话：616-931-3505。本新闻稿由CLEAR认证个人发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BD6J9T35.USD","BK4124","BK4232","GNTX","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164246465","title":"新闻稿：Septerna任命资深行业专家Rajiv Patni医学博士担任首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1164246465","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164246465?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:05","pubTimestamp":1787659519,"startTime":"0","endTime":"0","summary":"南旧金山，2026年8月25日——Septerna, Inc.，一家致力于开创G蛋白偶联受体药物发现新纪元的临床阶段生物技术公司，今日宣布任命Rajiv Patni医学博士为首席医疗官。Patni博士是一位兼具医师与科学家身份的生物制药高管，拥有超过25年领导研发、监管及医学事务组织的丰富经验。“在我的职业生涯中，我多次在研发轨迹的转折点加入公司，而Septerna正处在这一阶段，”Patni博士表示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","GPCR","BK4599","BK4007","R","BK4232","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185070568","title":"新闻稿：Oruka Therapeutics任命Todd Edwards为首席商务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1185070568","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185070568?lang=zh_cn&edition=full","pubTime":"2026-08-25 04:04","pubTimestamp":1787601874,"startTime":"0","endTime":"0","summary":"加州门洛帕克，2026年8月24日——Oruka Therapeutics, Inc.是一家临床阶段的生物技术公司，致力于开发新型生物制剂，旨在为斑块状银屑病和化脓性汗腺炎等慢性皮肤病的治疗树立新标准。该公司今日宣布，任命Todd Edwards为首席商务官，自2026年8月24日起生效。他此前在Arcutis Biotherapeutics, Inc.担任执行副总裁兼首席商务官，期间领导了ZORYVE产品线的转型——重建了银屑病商业组织，推出了特应性皮炎和脂溢性皮炎的新适应症，并实现了持续的收入增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","LU0109394709.USD","LU0889565916.HKD","ORKA","BK4232","BK4007","LENZ","LU0320765992.SGD","BK4539","BK4139","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160126283","title":"新闻稿：复宏汉霖发布2026年中期业绩——盈利持续跃升，全球价值兑现加速，迈向C-MNC步伐加快","url":"https://stock-news.laohu8.com/highlight/detail?id=1160126283","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160126283?lang=zh_cn&edition=full","pubTime":"2026-08-21 21:03","pubTimestamp":1787317411,"startTime":"0","endTime":"0","summary":"上海，2026年8月21日 /PRNewswire/ -- 8月21日，复宏汉霖公布其2026财年中期业绩。2026年上半年，复宏汉霖实现非国际财务报告准则利润人民币5.723亿元，同比大幅增长46.7%；调整后息税折旧摊销前利润为人民币9.041亿元，同比增长35.2%。关键财务及运营指标保持稳健上行态势。得益于核心产品在全球市场的持续放量，以及全价值链端到端的精益运营，公司的收入规模与盈利质量正同步增强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4233","R","BK4604","HK0000320223.HKD","TM","02696","UK","BK4588","BK1161","BK4555","BK4205","BK4528","HK0000165453.HKD","03160","HK0000306701.USD","HK0000320264.USD","PRGS","HK0000306685.HKD","BK4232","BK4099","LU2065732104.USD","BK4022","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113095677","title":"LifeVantage宣布季度股息派发计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1113095677","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113095677?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:03","pubTimestamp":1787313829,"startTime":"0","endTime":"0","summary":"盐湖城，2026年8月21日——LifeVantage Corporation，一家致力于通过细胞层面激活最佳健康过程的领先健康与保健公司，今日宣布其董事会已批准每股普通股0.050美元的季度现金股息。该股息将于2026年9月15日支付，登记截止日为2026年9月1日营业结束时在册的所有股东。LifeVantage Corporation，作为“激活”领域的先锋企业，是营养基因组学的开创者——这一学科研究营养及天然化合物如何解锁基因及其内在的健康密码。LifeVantage成立于2003年，总部位于犹他州莱希市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4022","LFVN","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163692170","title":"Meritage Homes宣布季度现金股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1163692170","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163692170?lang=zh_cn&edition=full","pubTime":"2026-08-21 02:50","pubTimestamp":1787251837,"startTime":"0","endTime":"0","summary":"亚利桑那州斯科茨代尔，2026年8月20日——美国第五大住宅建筑商Meritage Homes Corporation今日宣布，其董事会已批准派发每股0.48美元的季度股息。该股息将于2026年9月30日支付，登记截止日期为2026年9月15日交易收盘时。Meritage是美国第五大上市住宅建筑商，该排名基于2025年交付的房屋数量。在41年的发展历程中，Meritage已累计交付超过21万套住宅，并以其独特的设计风格、优质的施工质量以及屡获殊荣的客户体验而闻名。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4088","MTH","XHB","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147388028","title":"新闻稿：Lifetime Brands宣布完成6000万美元第二留置权定期贷款及2亿美元ABL融资额度的修订与展期","url":"https://stock-news.laohu8.com/highlight/detail?id=1147388028","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147388028?lang=zh_cn&edition=full","pubTime":"2026-08-18 04:16","pubTimestamp":1786997805,"startTime":"0","endTime":"0","summary":"纽约州加登城，2026年8月17日——生活时光品牌家具作为全球领先的家居品牌消费品设计商、开发商和营销商，今日宣布已完成其信贷设施的再融资。该公司现有的B期定期贷款已被一笔由Pathlight Capital提供的新6000万美元第二留置权定期贷款所取代，同时，由摩根大通担任代理行的2亿美元资产基础循环信贷额度也已获得修订和展期。新第二留置权定期贷款与修订后的ABL融资额度均于2031年8月到期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","03160","BK4099","R","BK4585","BK4180","BK4022","BK4604","LCUT","TM","PRTO","BK4555","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166097486","title":"Madrigal任命John C. Reed博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1166097486","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166097486?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:03","pubTimestamp":1786536220,"startTime":"0","endTime":"0","summary":"康舍霍肯，宾夕法尼亚州，2026年8月12日——专注于代谢功能障碍相关脂肪性肝炎新型疗法开发的生物制药公司Madrigal Pharmaceuticals, Inc.今日宣布，已任命John C. Reed医学博士、哲学博士为其董事会成员。Reed博士目前担任强生公司创新医学研发执行副总裁，并是J&J执行委员会成员。Madrigal董事会主席Julian Baker表示：\"非常欢迎John Reed加入Madrigal。Madrigal首席执行官Bill Sibold补充道：\"John的任命体现了Madrigal对科学卓越和长期创新的持续承诺。Madrigal Pharmaceuticals、Rezdiffra及相关标识均为Madrigal Pharmaceuticals, Inc.的商标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MDGL","BK4232","BK4022","BK4585","BK4139","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193936221","title":"数字房地产信托公司宣布普通股与优先股季度现金股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1193936221","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193936221?lang=zh_cn&edition=full","pubTime":"2026-08-12 04:10","pubTimestamp":1786479046,"startTime":"0","endTime":"0","summary":"德克萨斯州奥斯汀，2026年8月11日 —— 全球最大的云和运营商中立数据中心平台——数字房地产信托公司今日宣布，其董事会已授权2026年第三季度普通股及优先股的季度现金股息。数字房地产信托公司董事会批准，向截至2026年9月15日营业结束时登记在册的普通股股东，派发每股1.22美元的现金股息。数字房地产信托公司通过提供全面的数据中心、主机托管和互联解决方案，将企业与数据紧密连接。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCHH","BK4585","VGSR","DLR","DTCR","BK4566","IYRI","CRED","IDGT","FRI","SRVR","RNTY","R","PSR","USRT","DTRE","VIG","BK4222","JPRE","RITA","BBRE","IYR","BK4232","PPTY","RWO","JRE","BK4022","BK4588","BK4084","REAI","WTRE","BK4529","REET"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168267209","title":"Duos Technologies集团完成向Sandbank Acosta出售子公司Duos Technologies的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1168267209","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168267209?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:39","pubTimestamp":1786048776,"startTime":"0","endTime":"0","summary":"佛罗里达州杰克逊维尔，2026年8月6日 —— Duos Technologies集团，一家领先的自适应、模块化及可扩展边缘数据中心解决方案提供商，今日宣布已完成将其全资铁路技术子公司——Duos Technologies出售给佛罗里达有限责任公司Sandbank Acosta。交易完成后，DTI将以DuosTI品牌作为一家独立的私营公司运营，由新任总裁Javier Acosta领导。此次剥离完成了Duos在2026年3月宣布的战略重组，使公司能够将资源集中于边缘数据中心和AI基础设施业务，具体由Duos Edge AI和Duos Technology Solutions两家子公司负责。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","DUOT","QTOC","BK4022","AIPO","BERZ","CHAT","AGIX","BK4097","AIBU","VTHR","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193281325","title":"新闻稿：Rani Therapeutics 任命 Michelle Gilson 加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1193281325","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193281325?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:12","pubTimestamp":1785845578,"startTime":"0","endTime":"0","summary":"加利福尼亚州圣何塞，2026年8月4日——专注于口服生物制剂递送的临床阶段生物治疗公司 Rani Therapeutics Holdings, Inc.今日宣布，任命 Michelle Gilson 为其董事会成员。Gilson 女士将担任审计委员会主席。“Michelle 兼具深厚的资本市场专业知识和在高增长生物技术公司担任财务领导的实际经验，这使她成为我们董事会的一位卓越新成员，”Rani Therapeutics 首席执行官 Talat Imran 表示。“能在公司如此关键的时期加入 Rani Therapeutics 董事会，我深感荣幸，”Michelle Gilson 说道。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4022","R","BK4007","BK4539","BK4139","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187966317","title":"赛托姆X疗法任命亚历杭德拉·卡瓦哈尔为首席法务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1187966317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187966317?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:02","pubTimestamp":1785758545,"startTime":"0","endTime":"0","summary":"——在掩蔽型、条件性激活生物制剂领域处于领先地位的赛托姆X疗法公司，今日正式宣布任命亚历杭德拉·卡瓦哈尔为首席法务官。在此职位上，卡瓦哈尔女士将全力支持公司的战略规划、运营执行及管线项目推进。“在这个关键节点，能够加入赛托姆X并为其愿景贡献力量，我倍感振奋，”卡瓦哈尔女士说道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","BK4139","R","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107772972","title":"新闻稿：Medicus Pharma 任命 Faisal Mehmud 博士为英国子公司 Antev Limited 首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1107772972","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107772972?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:33","pubTimestamp":1785756837,"startTime":"0","endTime":"0","summary":"费城，2026年8月3日——生物科技与生命科学公司 Medicus Pharma Ltd.今日宣布，任命Faisal Mehmud医学博士、皇家内科医师学会会员为英国子公司Antev Limited的首席执行官，自2026年8月30日起生效。该公司专注于推进新型且潜在颠覆性治疗资产的临床开发项目。Mehmud博士将继续担任Medicus的首席医疗官和Antev的联合主席。此次任命进一步加强了Medicus的整合领导架构。Mehmud博士接替了Amit Kohli，后者自2025年8月29日Medicus完成对Antev的收购以来一直担任临时首席执行官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4139","MRCP","BK4232","UBCP","MDCX","BCC","BK4567","BK4211","R","BK4104","BK4205","BK4022","UK","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130963768","title":"新闻稿：Seer股东投票全数通过，2026年度股东大会七位董事候选人成功连任","url":"https://stock-news.laohu8.com/highlight/detail?id=1130963768","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130963768?lang=zh_cn&edition=full","pubTime":"2026-07-29 05:41","pubTimestamp":1785274872,"startTime":"0","endTime":"0","summary":"加利福尼亚州雷德伍德城，2026年7月28日——Seer, Inc.今日宣布，根据2026年度股东大会的初步投票结果，公司股东已投票决定，全数通过七位董事候选人的连任提案。这七位候选人分别是：Omid Farokhzad、Meeta Gulyani、Robert Langer、Terrance McGuire、Dipchand  Nishar、Isaac Ro以及Nicolas Roelofs。他们将共同组成Seer的董事会。今日公布的投票结果仅为初步数据，最终结果将由独立选举监察员进行统计和认证。此类前瞻性声明基于Seer的信念和假设，以及截至本通讯发布之日其可获得的信息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4121","BK4232","BK4022","SEER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197206772","title":"纳斯制药任命资深药企高管 Brendan P. O'Grady 为首席执行官，引领战略增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1197206772","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197206772?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:35","pubTimestamp":1785238543,"startTime":"0","endTime":"0","summary":"以色列特拉维夫，2026年7月28日——纳斯制药有限公司是一家专注于创新鼻内产品开发的临床阶段制药公司。今日，该公司宣布任命药界资深人士 Brendan P. O'Grady 为其新任首席执行官。O'Grady 先生将引领公司迈入下一增长阶段，其首要任务是释放 NS002 的商业潜力，推进公司产品管线及业务发展计划，并最大化其专有 Nasax 鼻内给药技术平台的价值。此次领导层交接已于2026年7月27日生效，O'Grady 先生接替 Dan Teleman 的职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DBB","BK4022","BK4232","R","NSRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100422595","title":"新闻稿：CytomX Therapeutics 任命 Charles Fuchs 医学博士、公共卫生学硕士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1100422595","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100422595?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:01","pubTimestamp":1785153661,"startTime":"0","endTime":"0","summary":"南旧金山，加利福尼亚州，2026年7月27日—— 隐蔽型、条件性激活生物制剂领域的领军企业 CytomX Therapeutics, Inc.今日宣布，任命 Charles Fuchs 医学博士、公共卫生学硕士为其董事会成员。他是一名获得认证的医学肿瘤学家，拥有哈佛医学院的医学博士学位和哈佛 T.H. Chan 公共卫生学院的公共卫生学硕士学位。通过其 PROBODY 治疗平台开创一条创新的局部化生物制剂管线，CytomX 的愿景是为癌症治疗创造更安全、更有效的疗法。CytomX 的临床阶段管线包括 varsetatug masetecan和 CX-801。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","BK4139","R","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ryder.com;investors.ryder.com","stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0479},{"period":"3month","weight":-0.0943},{"period":"6month","weight":0.2438},{"period":"1year","weight":0.285},{"period":"ytd","weight":0.2464}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"莱德系统公司是一家成立于1933年的佛罗里达州企业，是全球领先的运输和供应链管理解决方案提供商。该公司提供从港口到门的全流程解决方案，整合供应链的各个环节，包括国际入境物流和跨境物流、车队和运输管理、仓储、制造支持以及多渠道最终交付。其互补的业务板块提供广泛的增值解决方案，为客户打造无缝衔接的端到端物流网络，旨在降低复杂性，并提升整个货物流转的速度、可靠性和效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.019416},{"month":2,"riseRate":0.586957,"avgChangeRate":0.011618},{"month":3,"riseRate":0.565217,"avgChangeRate":0.006717},{"month":4,"riseRate":0.531915,"avgChangeRate":0.02614},{"month":5,"riseRate":0.531915,"avgChangeRate":0.008544},{"month":6,"riseRate":0.468085,"avgChangeRate":0.002602},{"month":7,"riseRate":0.595745,"avgChangeRate":0.031186},{"month":8,"riseRate":0.425532,"avgChangeRate":-0.007671},{"month":9,"riseRate":0.510638,"avgChangeRate":-0.006944},{"month":10,"riseRate":0.543478,"avgChangeRate":0.00111},{"month":11,"riseRate":0.630435,"avgChangeRate":0.027401},{"month":12,"riseRate":0.543478,"avgChangeRate":0.009358}],"exchange":"NYSE","name":"瑞德系统","nameEN":"Ryder"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞德系统(R)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞德系统,R,瑞德系统股票,瑞德系统股票老虎,瑞德系统股票老虎国际,瑞德系统行情,瑞德系统股票行情,瑞德系统股价,瑞德系统股市,瑞德系统股票价格,瑞德系统股票交易,瑞德系统股票购买,瑞德系统股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞德系统(R)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}